Julie L. Blum, Ph.D.
Affiliations: | 2006 | Johns Hopkins University, Baltimore, MD |
Area:
Molecular BiologyGoogle:
"Julie Blum"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Nancy Davidson | grad student | 2006 | Johns Hopkins | |
| (Epigenetic regulation of estrogen receptor alpha in human breast cancer cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| O'Shaughnessy JA, Koeppen H, Xiao Y, et al. (2015) Patients with Slowly Proliferative Early Breast Cancer have Low 5-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Levin MK, Wang K, Yelensky R, et al. (2015) Genomic alterations in DNA repair and chromatin remodeling genes in estrogen receptor-positive metastatic breast cancer patients with exceptional responses to capecitabine. Cancer Medicine |
| Delaloge S, Wolp-Diniz R, Byrski T, et al. (2014) Activity of trabectedin in germline BRCA1/2-mutated metastatic breast cancer: results of an international first-in-class phase II study. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 25: 1152-8 |
| Kotsopoulos J, Lubinski J, Moller P, et al. (2014) Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers. Breast Cancer Research and Treatment. 143: 579-86 |
| Glück S, Russell C, O'Shaughnessy J, et al. (2013) Treatment effect of capecitabine and docetaxel or docetaxel alone by oestrogen receptor status in patients with metastatic breast cancer: results of an exploratory analysis. Breast (Edinburgh, Scotland). 22: 1087-93 |
| Choudhury S, Almendro V, Merino VF, et al. (2013) Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. Cell Stem Cell. 13: 117-30 |
| Craig DW, O'Shaughnessy JA, Kiefer JA, et al. (2013) Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities. Molecular Cancer Therapeutics. 12: 104-16 |
| Kotsopoulos J, Lubinski J, Lynch HT, et al. (2012) Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers Cancer Epidemiology Biomarkers and Prevention. 21: 1089-1096 |
| Rebbeck TR, Mitra N, Domchek SM, et al. (2011) Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes. Cancer Research. 71: 5792-805 |
| Spurdle AB, Marquart L, McGuffog L, et al. (2011) Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1032-8 |